WAVE Life Sciences Ltd.
WVE
$6.59
$0.0450.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -260.25% | 147.35% | -87.65% | -4.33% | -94.13% |
| Total Depreciation and Amortization | 0.37% | -0.09% | -0.64% | -0.23% | -0.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 52.68% | -8.13% | 1.32% | 20.96% | 22.49% |
| Change in Net Operating Assets | 70.27% | -914.53% | 4,858.91% | 97.09% | 67.78% |
| Cash from Operations | -44.43% | 6.09% | -69.21% | 17.84% | -0.58% |
| Capital Expenditure | -91.86% | 77.55% | -636.54% | 87.53% | -17.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -91.86% | 77.55% | -636.54% | 87.53% | -17.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -88.13% | -81.54% | 28,942.27% | -95.50% | -84.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.17% | -- | -- | -- |
| Cash from Financing | -88.12% | -82.83% | 31,101.53% | -95.50% | -84.56% |
| Foreign Exchange rate Adjustments | 156.31% | -185.83% | 248.15% | -9.46% | -227.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -566.11% | -105.64% | 682.62% | -38.81% | -132.13% |